Article Versions Notes

Barras M, Schmitz L, Braumann C, Uhl W, Skrygan M, Buchholz M, Meyer T, Stockfleth E, Müller T, Becker JC, et al. An In Vitro Pilot Study Investigating the Antineoplastic Effects of GP-2250 on Cutaneous Squamous Cell Carcinoma Cell Lines: Preliminary Results. Dermato. 2023; 3(1):85-96. https://doi.org/10.3390/dermato3010007

Barras, Milan, Lutz Schmitz, Chris Braumann, Waldemar Uhl, Marina Skrygan, Marie Buchholz, Thomas Meyer, Eggert Stockfleth, Thomas Müller, Jürgen C. Becker, and et al. 2023. "An In Vitro Pilot Study Investigating the Antineoplastic Effects of GP-2250 on Cutaneous Squamous Cell Carcinoma Cell Lines: Preliminary Results" Dermato 3, no. 1: 85-96. https://doi.org/10.3390/dermato3010007

Barras, M., Schmitz, L., Braumann, C., Uhl, W., Skrygan, M., Buchholz, M., Meyer, T., Stockfleth, E., Müller, T., Becker, J. C., & Gambichler, T. (2023). An In Vitro Pilot Study Investigating the Antineoplastic Effects of GP-2250 on Cutaneous Squamous Cell Carcinoma Cell Lines: Preliminary Results. Dermato, 3(1), 85-96. https://doi.org/10.3390/dermato3010007